Zogenix, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- 327
- Market Cap
- -
- Website
- http://n/a
To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules
- Conditions
- Healthy
- Interventions
- Drug: HC-ER 20 mg capsule (fasted)Drug: HC-ER 20 mg capsule (fed)
- First Posted Date
- 2014-04-17
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02117141
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- Drug: Risperidone-SABER
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01592110
- Locations
- 🇺🇸
Glendale Adventist Medical Center, Glendale, California, United States
Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain
- First Posted Date
- 2010-05-04
- Last Posted Date
- 2022-11-09
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 424
- Registration Number
- NCT01115569
- Locations
- 🇺🇸
Stamford Therapeutics Consortium, Stamford, Connecticut, United States
🇺🇸Pain Institute of California, Bakersfield, California, United States
🇺🇸Georgia Institute for Clinical Research, LLC, Marietta, Georgia, United States
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
- Conditions
- Back Pain Lower Back Chronic
- Interventions
- Drug: Hydrocodone bitartrateDrug: Placebo
- First Posted Date
- 2010-03-05
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 510
- Registration Number
- NCT01081912
- Locations
- 🇺🇸
Advanced Clinical Research Institute, Anaheim, California, United States
🇺🇸Perimeter Institute for Clinical Research, Inc., Atlanta, Georgia, United States
🇺🇸Georgia Institute for Clinical Research, LLC, Marietta, Georgia, United States
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
- First Posted Date
- 2009-11-20
- Last Posted Date
- 2011-12-29
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 246
- Registration Number
- NCT01016834
- Locations
- 🇺🇸
C. Phillip O'Carroll, MD, Inc, Newport Beach, California, United States
🇺🇸California Medical Clinic for Headache, Santa Monica, California, United States
🇺🇸Comprehensive Neurosciences Inc, Atlanta, Georgia, United States
A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs
- Conditions
- Healthy
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT00620425
A Study on the Intraject Instructions for Use
- Conditions
- Healthy
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT00619554
A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System
- Conditions
- PharmacokineticsBioequivalence
- Interventions
- Device: Sumatriptan (via Intraject System)
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT00614029
- Locations
- 🇺🇸
Covance, Inc, Dallas, Texas, United States
A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack
- Conditions
- Migraine Headache
- Interventions
- Device: Intraject Sumatriptan
- First Posted Date
- 2007-09-17
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Zogenix, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT00530517